Financhill
Sell
19

STAF Quote, Financials, Valuation and Earnings

Last price:
$2.06
Seasonality move :
-20.23%
Day range:
$2.00 - $2.16
52-week range:
$1.08 - $5.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
--
Volume:
24.8K
Avg. volume:
79.1K
1-year change:
-53.29%
Market cap:
$3.1M
Revenue:
$190.9M
EPS (TTM):
-$36.69
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $278.5M $204.5M $197.8M $184.9M $190.9M
Revenue Growth (YoY) 6.73% -26.56% -3.3% -6.52% 3.24%
 
Cost of Revenues $230.2M $169.7M $163.9M $152.1M $162.3M
Gross Profit $48.3M $34.8M $33.9M $32.7M $28.5M
Gross Profit Margin 17.35% 17.02% 17.12% 17.71% 14.95%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $44.3M $37.5M $35.3M $32.6M $38.2M
Other Inc / (Exp) $2.6M -$2.1M $16.2M $726K $324K
Operating Expenses $47.7M $40.6M $38.1M $34.5M $40.1M
Operating Income $623K -$5.8M -$4.2M -$1.8M -$11.6M
 
Net Interest Expenses $8.5M $7.8M $4.2M $3.7M $5.5M
EBT. Incl. Unusual Items -$5.2M -$15.7M $7.8M -$4.7M -$16.7M
Earnings of Discontinued Ops. -- -- -- -$12.5M -$9M
Income Tax Expense -$335K -$100K -$357K -$222K $304K
Net Income to Company -$4.9M -$15.6M $8.2M -$17M -$26M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.9M -$15.6M $8.2M -$17M -$26M
 
Basic EPS (Cont. Ops) -$540.00 -$1,584.00 $33.00 -$80.40 -$54.00
Diluted EPS (Cont. Ops) -$540.00 -$1,584.00 $33.00 -$80.40 -$54.00
Weighted Average Basic Share $13.7K $15K $95.2K $211.4K $482.1K
Weighted Average Diluted Share $13.7K $15K $106.3K $211.4K $482.1K
 
EBITDA $8.2M -$3.2M $16.1M $2.3M -$8M
EBIT $3.3M -$7.9M $12M -$1M -$11.3M
 
Revenue (Reported) $278.5M $204.5M $197.8M $184.9M $190.9M
Operating Income (Reported) $623K -$5.8M -$4.2M -$1.8M -$11.6M
Operating Income (Adjusted) $3.3M -$7.9M $12M -$1M -$11.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $48.6M $47.5M $66.1M $49.5M $46.1M
Revenue Growth (YoY) -27.75% -2.34% 39.2% -25.08% -6.94%
 
Cost of Revenues $40.3M $37.9M $53.8M $41.9M $39.9M
Gross Profit $8.3M $9.6M $12.3M $7.7M $6.2M
Gross Profit Margin 17.11% 20.26% 18.64% 15.47% 13.37%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $9.4M $8.5M $11M $8.6M $7M
Other Inc / (Exp) $823K $9.4M $1.7M -$1.4M -$911K
Operating Expenses $10.2M $9.2M $11.8M $9.2M $7.5M
Operating Income -$1.8M $473K $495K -$1.5M -$1.3M
 
Net Interest Expenses $1.7M $1M $1.1M $1.3M $574K
EBT. Incl. Unusual Items -$2.8M $8.8M $1.1M -$4.2M -$2.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$118K $131K $62K $21K $51K
Net Income to Company -$2.6M $8.7M $1M -$4.3M -$2.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$2.6M $8.7M $1M -$4.3M -$2.8M
 
Basic EPS (Cont. Ops) -$234.00 $70.00 $4.30 -$7.05 -$3.22
Diluted EPS (Cont. Ops) -$234.00 $68.90 $4.30 -$7.05 -$3.22
Weighted Average Basic Share $14.6K $107.9K $240.2K $435K $884.6K
Weighted Average Diluted Share $14.6K $110.8K $240.2K $435K $884.6K
 
EBITDA $134K $10.8M $3.2M -$2M -$1.5M
EBIT -$1M $9.9M $2.2M -$2.9M -$2.2M
 
Revenue (Reported) $48.6M $47.5M $66.1M $49.5M $46.1M
Operating Income (Reported) -$1.8M $473K $495K -$1.5M -$1.3M
Operating Income (Adjusted) -$1M $9.9M $2.2M -$2.9M -$2.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $214.5M $200.8M $225.9M $155.6M $176.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $176.4M $165.9M $187.3M $132M $153.2M
Gross Profit $38.1M $34.9M $38.6M $23.6M $23.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $40.4M $34.7M $39.9M $26.2M $34.1M
Other Inc / (Exp) -$2.2M $20.5M -$2.7M -$2.1M $2.6M
Operating Expenses $43.4M $37.6M $42.7M $27.5M $36.1M
Operating Income -$5.3M -$2.7M -$4.1M -$3.9M -$12.4M
 
Net Interest Expenses $8.8M $5M $3.8M $4.3M $5.1M
EBT. Incl. Unusual Items -$16.2M $12.9M -$10.7M -$10.3M -$14.9M
Earnings of Discontinued Ops. -- -- -- -$853K $901K
Income Tax Expense -$286K $248K -$394K -$219K $388K
Net Income to Company -$15.9M $12.6M -$10.3M -$23.4M -$23.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$15.9M $12.6M -$10.3M -$23.4M -$23.4M
 
Basic EPS (Cont. Ops) -$1,209.00 -$379.60 -$64.49 -$87.36 -$33.01
Diluted EPS (Cont. Ops) -$1,209.00 -$389.50 -$64.49 -$87.36 -$36.69
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$1.7M $22.2M -$2.6M -$3.6M -$6.9M
EBIT -$7.4M $17.8M -$6.9M -$6.1M -$10M
 
Revenue (Reported) $214.5M $200.8M $225.9M $155.6M $176.8M
Operating Income (Reported) -$5.3M -$2.7M -$4.1M -$3.9M -$12.4M
Operating Income (Adjusted) -$7.4M $17.8M -$6.9M -$6.1M -$10M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $150.7M $147M $175.1M $145.8M $131.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $124.2M $120.3M $143.7M $123.6M $114.4M
Gross Profit $26.5M $26.7M $31.4M $22.2M $17.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $28.6M $25.8M $30.4M $24.1M $20M
Other Inc / (Exp) -$3M $19.7M $738K -$2.1M -$656K
Operating Expenses $30.9M $27.9M $32.6M $25.5M $21.5M
Operating Income -$4.4M -$1.3M -$1.2M -$3.3M -$4.2M
 
Net Interest Expenses $6.3M $3.4M $3M $3.7M $3.3M
EBT. Incl. Unusual Items -$13.6M $15M -$3.5M -$9.1M -$8.1M
Earnings of Discontinued Ops. -- -- -- -$853K $901K
Income Tax Expense -$247K $101K $65K $68K $151K
Net Income to Company -$13.4M $14.9M -$3.6M -$10M -$7.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$13.4M $14.9M -$3.6M -$10M -$7.4M
 
Basic EPS (Cont. Ops) -$987.00 $94.40 -$21.90 -$24.96 -$12.46
Diluted EPS (Cont. Ops) -$987.00 $84.50 -$21.90 -$24.96 -$12.46
Weighted Average Basic Share $52.9K $220.4K $591.4K $928.6K $2M
Weighted Average Diluted Share $52.9K $236.7K $591.4K $928.6K $2M
 
EBITDA -$3.9M $21.4M $2.7M -$3.1M -$2.7M
EBIT -$7.4M $18.4M -$461K -$5.5M -$5M
 
Revenue (Reported) $150.7M $147M $175.1M $145.8M $131.7M
Operating Income (Reported) -$4.4M -$1.3M -$1.2M -$3.3M -$4.2M
Operating Income (Adjusted) -$7.4M $18.4M -$461K -$5.5M -$5M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.2M $8.3M $4.6M $1.5M $721K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $26.6M $24.6M $20.7M $21.3M $17.8M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $842K $1.3M $988K $1.5M $1.1M
Total Current Assets $28.6M $36.2M $26.3M $35M $28.7M
 
Property Plant And Equipment $6.4M $4.5M $6.4M $6.1M $5.3M
Long-Term Investments -- -- -- -- --
Goodwill $31M $27M $23.8M $19.9M $19.9M
Other Intangibles $19.5M $16M $13.6M $12.8M $11.2M
Other Long-Term Assets $3.2M $3.2M $3.5M $7.8M $5.6M
Total Assets $88.8M $86.9M $73.7M $81.7M $70.7M
 
Accounts Payable $1.4M $28K $2.7M $4.1M $4.6M
Accrued Expenses $18.9M $17.3M $10M $6.8M $9.6M
Current Portion Of Long-Term Debt $38.5M $14.9M $9.2M -- $9.8M
Current Portion Of Capital Lease Obligations $1.8M $1.2M $1M $1M $1M
Other Current Liabilities $23.3M $23.5M $21.8M $35.8M $42.8M
Total Current Liabilities $84M $56.9M $44.7M $51M $74.1M
 
Long-Term Debt $360K $39.9M $279K $8.7M --
Capital Leases -- -- -- -- --
Total Liabilities $89.2M $105M $50.4M $73.3M $78.5M
 
Common Stock $14K $12K $1K $1K $1K
Other Common Equity Adj -$58K $223K $162K -$2.2M $31K
Common Equity -$380K -$18.1M $23.3M $8.4M -$7.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$367K -$18.1M $23.3M $8.4M -$7.8M
 
Total Liabilities and Equity $88.8M $86.9M $73.7M $81.7M $70.7M
Cash and Short Terms $1.2M $8.3M $4.6M $1.5M $721K
Total Debt $38.8M $54.8M $9.5M $8.7M $9.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $7.4M $2.2M $1.8M $681K $1.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $23.5M $24.2M $29.9M $25.2M $19.5M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.2M $1.5M $3.2M $1.8M $1.7M
Total Current Assets $35.4M $28M $34.8M $27.7M $22.8M
 
Property Plant And Equipment $4.5M $6.7M $10M $9.6M $4.9M
Long-Term Investments -- -- -- -- --
Goodwill $26.3M $26.9M $27.7M $19.9M $19.9M
Other Intangibles $16.2M $14.2M $16.6M $15.4M $10M
Other Long-Term Assets $2.9M $3.2M $6.5M $8M $4.8M
Total Assets $85.3M $79.1M $95.6M $80.6M $62.2M
 
Accounts Payable $14.4M $13.2M $16M $19.1M $12.4M
Accrued Expenses -- $125K $215K $227K $812K
Current Portion Of Long-Term Debt $14.9M $13.9M $345K -- $19.6M
Current Portion Of Capital Lease Obligations $1.2M $1.1M $1M $1.3M $1.1M
Other Current Liabilities $18.4M $19.8M $31M $26M $25.4M
Total Current Liabilities $51.9M $48.2M $48.6M $46.7M $71.6M
 
Long-Term Debt $42.4M $433K $9M $9.7M --
Capital Leases -- -- -- -- --
Total Liabilities $100.6M $57.2M $75.3M $72M $76.9M
 
Common Stock $14K $1K $1K $1K $1K
Other Common Equity Adj $286K $340K -$3.1M -$1.4M $31K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- $14K -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$15.3M $21.9M $20.3M $8.5M -$14.6M
 
Total Liabilities and Equity $85.3M $79.1M $95.6M $80.6M $62.2M
Cash and Short Terms $7.4M $2.2M $1.8M $681K $1.5M
Total Debt $57.2M $14.4M $9.4M $9.7M $19.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$4.9M -$15.6M $8.2M -$17M -$26M
Depreciation & Amoritzation $4.9M $4.8M $4.1M $3.3M $3.2M
Stock-Based Compensation $832K $637K $377K $623K $1.4M
Change in Accounts Receivable -$7.6M -$7.3M -$3.8M $3.4M $3.4M
Change in Inventories -- -- -- -- --
Cash From Operations -$10.8M -$14.3M -$14.6M -$9.3M -$11.7M
 
Capital Expenditures $510K $257K $249K $215K $320K
Cash Acquisitions -- $3.3M -- $2.5M --
Cash From Investing $13.5M $11.7M $7.1M $1.7M -$2M
 
Dividends Paid (Ex Special Dividend) -$1.5M -$3.3M -$591K -- --
Special Dividend Paid
Long-Term Debt Issued $2.5M $20.6M $130K $67K $2M
Long-Term Debt Repaid -$650K -$4.7M -$34.1M -$14K -$738K
Repurchase of Common Stock -- -$1.9M -$4.9M -- --
Other Financing Activities -$10.3M -$3.7M -$6.5M -$3.4M -$4.7M
Cash From Financing -$4.4M $11.6M $1.8M $7.4M $10.7M
 
Beginning Cash (CF) $3.2M $1.2M $10.3M $4.1M $1.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.8M $9M -$5.8M -$270K -$3M
Ending Cash (CF) $1.2M $10.3M $4.6M $1.5M $721K
 
Levered Free Cash Flow -$11.4M -$14.5M -$14.9M -$9.5M -$12M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$2.6M $8.7M $1M -$4.3M -$2.8M
Depreciation & Amoritzation $1.1M $949K $969K $889K $753K
Stock-Based Compensation $195K $15K $325K $227K $183K
Change in Accounts Receivable -$3.3M -$2.4M $1.7M $656K $540K
Change in Inventories -- -- -- -- --
Cash From Operations -$5.6M -$6.5M -$3.5M -$2.4M -$1.9M
 
Capital Expenditures $48K $90K $406K $76K $24K
Cash Acquisitions $3.3M -- -- -- --
Cash From Investing $5M $1.9M $1.2M $1.6M -$23K
 
Dividends Paid (Ex Special Dividend) -$1.9M -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$14K -- -- $2M --
Long-Term Debt Repaid -$1K -$10.7M -$135K -$900K --
Repurchase of Common Stock -- -- $14K -- --
Other Financing Activities -$677K $568K -$1.5M -$1.9M $2.1M
Cash From Financing -$2.6M $4M $2.3M $1.5M $2.1M
 
Beginning Cash (CF) $13.8M $2.9M $1.8M $76K $1.3M
Foreign Exchange Rate Adjustment $52K -$25K -$59K -$15K --
Additions / Reductions -$3.2M -$672K $33K $620K $234K
Ending Cash (CF) $10.7M $2.2M $1.8M $681K $1.5M
 
Levered Free Cash Flow -$5.6M -$6.6M -$3.9M -$2.5M -$1.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$15.9M $12.6M -$10.3M -$23.4M -$23.4M
Depreciation & Amoritzation $5.7M $4.3M $4.3M $2.5M $3.1M
Stock-Based Compensation $745K $453K $352K $1.5M $771K
Change in Accounts Receivable -$3.4M -$7.9M -$4.5M $9.7M $1.5M
Change in Inventories -- -- -- -- --
Cash From Operations -$14.8M -$13.1M -$13.1M -$11.8M -$4.5M
 
Capital Expenditures $321K $131K $868K -$366K $235K
Cash Acquisitions $3.3M -- $1.4M $1.1M --
Cash From Investing $13.3M $7M $7.8M $462K -$4.8M
 
Dividends Paid (Ex Special Dividend) -$2.6M -$1.4M -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2.8M -$31.3M -$5.2M -- --
Repurchase of Common Stock -- -$6.8M -- -- --
Other Financing Activities -$4.7M -$6.1M -$3.1M -$2.2M $499K
Cash From Financing $10.5M -$2.5M $5M $12.4M $8.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $9M -$8.5M -$355K $1.1M -$877K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$15.1M -$13.2M -$14M -$11.4M -$4.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$13.4M $14.9M -$3.6M -$10M -$7.4M
Depreciation & Amoritzation $3.4M $3M $3.2M $2.4M $2.3M
Stock-Based Compensation $534K $350K $325K $1.2M $545K
Change in Accounts Receivable -$4.8M -$5.3M -$6.1M $178K -$1.7M
Change in Inventories -- -- -- -- --
Cash From Operations -$10.9M -$9.8M -$8.3M -$10.7M -$3.6M
 
Capital Expenditures $226K $100K $719K $138K $53K
Cash Acquisitions $3.3M -- $1.4M -- --
Cash From Investing $9.9M $5.2M $6M $4.7M $2M
 
Dividends Paid (Ex Special Dividend) -$2.5M -$591K -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $20.6M $130K $67K $2M --
Long-Term Debt Repaid -$2.7M -$29.2M -$379K -$900K --
Repurchase of Common Stock -- -$4.9M -- -- --
Other Financing Activities -$5M -$7.4M -$4.1M -$2.9M $2.3M
Cash From Financing $10.4M -$3.6M -$358K $4.7M $2.3M
 
Beginning Cash (CF) $16M $17.7M $7.7M $2.7M $2.4M
Foreign Exchange Rate Adjustment $55K -$6K -$123K $19K --
Additions / Reductions $9.4M -$8.1M -$2.7M -$1.3M $777K
Ending Cash (CF) $25.4M $9.6M $4.9M $1.9M $3.2M
 
Levered Free Cash Flow -$11.1M -$9.9M -$9M -$10.9M -$3.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.45% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.01% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock